Abstract
Background
Despite growing demand for medicinal plants, there is little data about their use by patients with dyslipidemia. We aimed to determine the prevalence, pattern, and associated factors for the use of medicinal plants among patients with dyslipidemia.
Methods
A 17-item semi-structured questionnaire was filled out by 195 patients with dyslipidemia in a cross-sectional study carried out in two academic endocrinology clinics in Shiraz, Iran. The questionnaire comprised of three main domains of demographic data (6 questions), clinical data (2 of them), and data related to the use of medicinal plants (totally 9 questions).
Results
A total of 77.4% of patients took medicinal plants. The most common medicinal herbs used by dyslipidemic patients were Zataria multiflora, Cinnamomum zeylanicum, and Zingiber officinale. Duration of dyslipidemia was significantly longer in herbal users than non-herbal users (p=0.04). Patients believing that concomitant use of conventional drugs and herbal preparations had synergic positive effects in addition to those persuaded that herbal preparations possessed less side effects, were significantly more likely to use medicinal plants (p=0.008 and 0.005, respectively). Additionally, most of the medicinal herb users (87.4%) changed neither the pattern nor the dosage of their medications all during herbal preparations use.
Conclusions
This study demonstrated a high prevalence of medicinal plants’ use among patients with dyslipidemia, which was associated with the duration of dyslipidemia, patients’ viewpoints about herbal preparations’ synergic positive effects, and their fewer side effects.
Author contributions: MHH, MS, MH and MS participated in the design of the study. MHH, SHM and MH conducted the interviews and identified all medicinal plants reported. MH contributed to the statistical analysis. SHM and MHH wrote the first draft of the manuscript. All authors contributed to interpretation of the results and the final manuscript. All authors read and approved the final manuscript.
Research funding: Fasa University of Medical Sciences (Funder Id: 10.13039/501100006402), (96133)
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
[1] de Sereday MS, Gonzalez C, Giorgini D, De Loredo L, Braguinsky J, Cobenas C, et al. Prevalence of diabetes, obesity, hypertension and dyslipidemia in the central area of Argentina. Diabetes Metab 2004;30:335–9.10.1016/S1262-3636(07)70125-8Search in Google Scholar PubMed
[2] Ruixing Y, Fengping H, Shangling P, Dezhai Y, Weixiong L, Tangwei L, et al. Prevalence of dyslipidemia and its risk factors for the middle-aged and elderly in the Guangxi Hei Yi Zhuang and Han populations. J Investig Med 2006;54:191–200.10.2310/6650.2006.05050Search in Google Scholar PubMed
[3] Tabatabaei-Malazy O, Qorbani M, Samavat T, Sharifi F, Larijani B, Fakhrzadeh H. Prevalence of dyslipidemia in iran: a systematic review and meta-analysis study. Int J Prev Med 2014;5:373–93.Search in Google Scholar PubMed
[4] Mohammadbeigi A, Moshiri E, Mohammadsalehi N, Ansari H, Ahmadi A. Dyslipidemia prevalence in Iranian adult men: the impact of population-based screening on the detection of undiagnosed patients. World J Mens Health 2015;33:167–73.10.5534/wjmh.2015.33.3.167Search in Google Scholar PubMed PubMed Central
[5] Crawford AG, Cote C, Couto J, Daskiran M, Gunnarsson C, Haas K, et al. Prevalence of obesity, type II diabetes mellitus, dyslipidemia, and hypertension in the United States: findings from the GE centricity electronic medical record database. Popul Health Manag 2010;13:151–61.10.1089/pop.2009.0039Search in Google Scholar PubMed
[6] Hatmi ZN, Tahvildari S, Gafarzadeh Motlag A, Sabouri Kashani A. Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC Cardiovasc Disord 2007;7:32.10.1186/1471-2261-7-32Search in Google Scholar PubMed PubMed Central
[7] Hasani-Ranjbar S, Zahedi HS, Abdollahi M, Larijani B. Trends in publication of evidence-based traditional Iranian medicine in endocrinology and metabolic disorders. J Diabetes Metab Disord 2013;12:49.10.1186/2251-6581-12-49Search in Google Scholar PubMed PubMed Central
[8] World Health Organization. WHO traditional medicine strategy 2002–2005. Geneva: World Health Organization, 2002.Search in Google Scholar
[9] Wilkinson JM, Stevens MJ. Use of complementary and alternative medical therapies (CAM) by patients attending a regional comprehensive cancer care centre. J Complement Integr Med 2014;11:139–45.10.1515/jcim-2013-0048Search in Google Scholar PubMed
[10] Jabbari M, Daneshfard B, Emtiazy M, Khiveh A, Hashempur MH. Biological effects and clinical applications of Dwarf Elder (Sambucus ebulus L): a review. J Evid Based Complementary Altern Med 2017;22:996–1001.10.1177/2156587217701322Search in Google Scholar PubMed PubMed Central
[11] Lee G, Charn T, Chew Z, Ng T. Complementary and alternative medicine use in patients with chronic diseases in primary care is associated with perceived quality of care and cultural beliefs. Fam Pract 2004;21:654–60.10.1093/fampra/cmh613Search in Google Scholar PubMed
[12] Hasan SS, Ahmed SI, Bukhari NI, Loon WC. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complement Ther Clin Pract 2009;15:152–7.10.1016/j.ctcp.2009.02.003Search in Google Scholar PubMed
[13] Wazaify M, Alawwa I, Yasein N, Al-Saleh A, Afifi FU. Complementary and alternative medicine (CAM) use among Jordanian patients with chronic diseases. Complement Ther Clin Pract 2013;19:153–7.10.1016/j.ctcp.2013.03.001Search in Google Scholar PubMed
[14] Bregum F. The present status of medicinal plants in Bangladesh. Iran J Pharm Res 2010;3:34.Search in Google Scholar
[15] Tangkiatkumjai M, Boardman H, Walker DM. Herbal and dietary supplement use in Bangkok: a survey. J Complement Integr Med 2014;11:203–11.10.1515/jcim-2013-0016Search in Google Scholar PubMed
[16] Akrami R, Hashempur MH, Tavakoli A, Nimrouzi M, Sayadi M, Roodaki M, et al. Effects of Fumaria parviflora L on uremic pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled trial. Jundishapur J Nat Pharm Prod 2017;12:e39744.10.17795/jjnpp-39744Search in Google Scholar
[17] Spinks J, Johnston D, Hollingsworth B. Complementary and alternative medicine (CAM) use and quality of life in people with type 2 diabetes and/or cardiovascular disease. Complement Ther Med 2014;22:107–15.10.1016/j.ctim.2013.11.007Search in Google Scholar PubMed
[18] Dehghan M, Mokhtarabadi S, Heidari FG. Complementary and alternative medicine usage and its determinant factors among Iranian infertile couples. J Complement Integr Med 2018;15. DOI: 10.1515/jcim-2017-0138Search in Google Scholar PubMed
[19] Organisation mondiale de la santé. WHO global atlas of traditional, complementary and alternative medicine. Geneva: World Health Organization, 2005.Search in Google Scholar
[20] Cheraghali AM Herbal medicine in the Islamic Republic of Iran. World Health Organization. 2016;4: 14. Available at: http://apps.who.int/medicinedocs/en/d/Js4923e/3.5.html#Js4923e.3.5Search in Google Scholar
[21] Hooper D, Field H, Dahlgren BE Useful plants and drugs of Iran and Iraq. Field Museum of Natural History. 1937.Search in Google Scholar
[22] Nowbandegani AS, Kiumarcy S, Rahmani F, Dokouhaki M, Khademian S, Zarshenas MM, et al. Ethnopharmacological knowledge of shiraz and Fasa in Fars region of Iran for diabetes mellitus. J Ethnopharmacol 2015;172:281–7.10.1016/j.jep.2015.06.017Search in Google Scholar PubMed
[23] Hassanzade Ajiri D Herbal life: traditional medicine gets a modern twist in Iran. 2016;4: 14. Available at: http://www.theguardian.com/world/iran-blog/2016/apr/11/iran-traditional-medicine-herbs-regulation-tehranbureauSearch in Google Scholar
[24] Hashempur MH, Heydari M, Mosavat SH, Heydari ST, Shams M. Complementary and alternative medicine use in Iranian patients with diabetes mellitus. J Integr Med 2015;13:319–25.10.1016/S2095-4964(15)60196-0Search in Google Scholar PubMed
[25] Kashani L, Hassanzadeh E, Mirzabeighi A, Akhondzadeh S. Knowledge, attitude and practice of herbal remedies in a group of infertile couples. Acta Med Iran 2013;51:189–94.Search in Google Scholar
[26] Fahimi F, Hrgovic I, El-Safadi S, Munstedt K. Complementary and alternative medicine in obstetrics: a survey from Iran. Arch Gynecol Obstet 2011;284:361–4.10.1007/s00404-010-1641-8Search in Google Scholar PubMed
[27] Sattari M, Dilmaghanizadeh M, Hamishehkar H, Mashayekhi SO. Self-reported use and attitudes regarding herbal medicine safety during pregnancy in Iran. Jundishapur J Nat Pharm Prod 2012;7:45.10.17795/jjnpp-3416Search in Google Scholar PubMed
[28] Tabatabaee M. Use of herbal medicine among pregnant women referring to Valiasr Hospital in Kazeroon, Fars, South of Iran. J Med Plants 2011;1:96–108.Search in Google Scholar
[29] Montazeri A, Sajadian A, Ebrahimi M, Akbari ME. Depression and the use of complementary medicine among breast cancer patients. Support Care Cancer 2005;13:339–42.10.1007/s00520-004-0709-zSearch in Google Scholar PubMed
[30] Montazeri A, Sajadian A, Ebrahimi M, Haghighat S, Harirchi I. Factors predicting the use of complementary and alternative therapies among cancer patients in Iran. Eur J Cancer Care 2007;16:144–9.10.1111/j.1365-2354.2006.00722.xSearch in Google Scholar
[31] Harirchian MH, Sahraian MA, Hosseinkhani A, Amirzargar N. Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis. Iran J Neurol 2014;13:13.Search in Google Scholar PubMed
[32] Yekta Z, Zamani A, Mehdizade M, Farajzadegan Z. Pattern of complementary and alternative medicine use in urban population. J Res Health Sci 2007;7:24–31.Search in Google Scholar PubMed
[33] Chang H, Wallis M, Tiralongo E. Use of complementary and alternative medicine among people living with diabetes: literature review. J Adv Nurs 2007;58:307–19.10.1111/j.1365-2648.2007.04291.xSearch in Google Scholar PubMed
[34] Sina I 1037, Al-Qanoon Fit-Tib (Principles in medicine). Reprinted in 1970 from Bulaq. Lebanon: edition Sader Publishing House Beirut.Search in Google Scholar
[35] Khorasani MA. Makhzan al Advieh. Tehran: Bavardaran Press Research institute for Islamic and Complementary Medicine, Iran University of Medical Sciences, 2001.Search in Google Scholar
[36] Khoshvaghti A, Nazifi S, Derakhshaniyan S, Akbarpour B. The effects of Zataria multiflora hydroalcoholic extract on some liver enzymes, cholesterol, triglyceride, HDL-cholesterol, LDL cholesterol, albumin and total protein in rat. J Basic Appl Sci 2012;8:217–22.10.6000/1927-5129.2012.08.01.33Search in Google Scholar
[37] Rao PV, Gan SH. Cinnamon: a multifaceted medicinal plant. Evid Based Complement Alternat Med 2014;2014:642942.10.1155/2014/642942Search in Google Scholar
[38] Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 2003;26:3215–8.10.2337/diacare.26.12.3215Search in Google Scholar PubMed
[39] Alizadeh-Navaei R, Roozbeh F, Saravi M, Pouramir M, Jalali F, Moghadamnia AA. Investigation of the effect of ginger on the lipid levels. A double blind controlled clinical trial. Saudi Med J 2008;29:1280–4.Search in Google Scholar
[40] Arablou T, Aryaeian N, Valizadeh M, Sharifi F, Hosseini A, Djalali M. The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus. Int J Food Sci Nutr 2014;65:515–20.10.3109/09637486.2014.880671Search in Google Scholar PubMed
[41] Kono S, Shinchi K, Ikeda N, Yanai F, Imanishi K. Green tea consumption and serum lipid profiles: a cross-sectional study in northern Kyushu, Japan. Prev Med 1992;21:526–31.10.1016/0091-7435(92)90060-USearch in Google Scholar PubMed
[42] Koo SI, Noh SK. Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem 2007;18:179–83.10.1016/j.jnutbio.2006.12.005Search in Google Scholar PubMed PubMed Central
[43] Xue WL, Li XS, Zhang J, Liu YH, Wang ZL, Zhang RJ. Effect of Trigonella foenum-graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr 2007;16:422–6.Search in Google Scholar PubMed
[44] Kassaian N, Azadbakht L, Forghani B, Amini M. Effect of fenugreek seeds on blood glucose and lipid profiles in type 2 diabetic patients. Int J Vitam Nutr Res 2009;79:34–9.10.1024/0300-9831.79.1.34Search in Google Scholar PubMed
[45] Rafraf M, Zemestani M, Asghari-Jafarabadi M. Effectiveness of chamomile tea on glycemic control and serum lipid profile in patients with type 2 diabetes. J Endocrinol Invest 2015;38:163–70.10.1007/s40618-014-0170-xSearch in Google Scholar PubMed
[46] Guo YT, Lan W. Effect of uigur traditional herb matricaria chamomile extract on serum lipid of experimental hyperl ipidmia rats. J Shandong Polytech Univ (NatSci Ed) 2013;2:009.Search in Google Scholar
[47] Solati M, Farshidfar G, Vakil MK, Saberi P, Kamalinajad M, Solati N. Effect of administration of Teucrium polium on blood glucose and lipid levels in streptozotocin-induced diabetic rats. Physiol Pharmacol. 2013;16:423–34Search in Google Scholar
[48] Ayoubi A, Omidi A, Valizade R, Mousaei A. Effect of hydroalcoholic extract of Aloe vera and Teucrium on serum glucose and lipid profile in streptozotocin diabetic male rats. J Birjand Univ Med Sci 2013;20:144–52.Search in Google Scholar
[49] Hosseini S, Jamshidi L, Mehrzadi S, Mohammad K, Najmizadeh AR, Alimoradi H, et al. Effects of juglans regia L. leaf extract on hyperglycemia and lipid profiles in type two diabetic patients: a randomized double-blind, placebo-controlled clinical trial. J Ethnopharmacol 2014;152:451–6.10.1016/j.jep.2014.01.012Search in Google Scholar PubMed
[50] Kwak JS, Kwon O. The effect of walnut (Juglans regia L.) intake on improvement of blood lipid levels and vascular health: a meta-analysis. J Nutr Health 2014;47:236–46.10.4163/jnh.2014.47.4.236Search in Google Scholar
[51] Hajhashemi V, Abbasi N. Hypolipidemic activity of Anethum graveolens in rats. Phytother Res 2008;22:372–5.10.1002/ptr.2329Search in Google Scholar PubMed
[52] Yazdanparast R, Alavi M. Antihyperlipidaemic and antihypercholesterolaemic effects of Anethum graveolens leaves after the removal of furocoumarins. Cytobios 2001;105:185–91.Search in Google Scholar PubMed
[53] Kojuri J, Vosoughi AR, Akrami M. Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients. Lipids Health Dis 2007;6:5.10.1186/1476-511X-6-5Search in Google Scholar PubMed PubMed Central
[54] Daher CF, Baroody KG, Baroody GM. Effect of Urtica dioica extract intake upon blood lipid profile in the rats. Fitoterapia 2006;77:183–8.10.1016/j.fitote.2006.01.010Search in Google Scholar PubMed
© 2019 Walter de Gruyter GmbH, Berlin/Boston
